Sika Injection-101 RC Flexible pur-injection foam 22.5 kg

Flexible PUR-Injection foam for temporary waterstopping

• No reaction takes place unless it is in direct contact with water
• Sika® Injection-101 RC can be injected as a single component system
• The free foaming expansion in contact with water is up to 40 times
• No reaction takes place unless it is in direct contact with water
• Sika® Injection-101 RC can be injected as a single component system
• The free foaming expansion in contact with water is up to 40 times
• The reaction speed (foam formation) is influenced by the temperatures of the mixed material, the structure and the contact water, plus the hydrodynamic conditions
• In cold temperatures (< + 10°C) Sika® Injection-101 RC can be accelerated using Sika® Injection-AC10
• Content: Part A 10 kg + Part B 12.5 kg

Field of application

• Sika® Injection-101 RC is used for the temporary waterstopping of high water intrusions in cracks, joints and cavities in concrete, brickwork and natural stonework.
• To achieve permanent watertight crack sealing, Sika® Injection-201 CE or Sika® Injection-203 should be injected subsequently.

Technical specifications

• Chemical Base: Water reactive 2-part polyurethane resin, solvent and CFC free
• Storage Conditions: Dry storage at temperatures from +5 °C up to +35 °C. Protect from direct sunlight and humidity.
• Density Part A: ~1.0 kg/l
• Density Part B: ~1.25 kg/lat 20 °C
• Viscosity Part A at 20 °C: ~140 mPa∙s
• Viscosity Part B at 20 °C: ~155 mPa∙s
• Shelf Life: 24 months shelf life from date of production if stored properly in undamaged, unopened, original sealed packaging.

Hazard Statements (CLP) - Sika Injection‐101 RC - A

Hazard Statements (H-Sentences)

• H315: Causes skin irritation.
• H319: Causes serious eye irritation.

Precautionary Statements (P-Sentences)

Prevention:

• P264: Wash skin thoroughly after handling.
• P280: Wear protective gloves/eye protection/face protection.

Response:

• P302 + P352: IF ON SKIN: Wash with plenty of water.
• P332 + P313: If skin irritation occurs: Get medical advice/attention.
• P337 + P313: If eye irritation persists: Get medical advice/attention.
• P362 + P364: Take off contaminated clothing and wash it before reuse.

Hazard Statements (CLP) - Sika Injection‐101 RC - B

Hazard Statements (H-Sentences)

• H315: Causes skin irritation.
• H317: May cause an allergic skin reaction.
• H319: Causes serious eye irritation.
• H332: Harmful if inhaled.
• H334: May cause allergy, asthma-like symptoms or breathing difficulties if inhaled.
• H335: May cause respiratory irritation.
• H351: Suspected of causing cancer.
• H373: May cause damage to organs through prolonged or repeated exposure if inhaled.

Precautionary Statements (P-Sentences)

Prevention:

• P201: Obtain special instructions before use.
• P260: Do not breathe mist or vapour.
• P264: Wash skin thoroughly after handling.
• P280: Wear protective gloves/protective clothing/eye protection/face protection.

Response:

• P304 + P340 + P312: IF INHALED: Move person to fresh air and keep comfortable for breathing. If feeling unwell, call a POISON CENTER/doctor.
• P342 + P311: If experiencing respiratory symptoms: Call a POISON CENTER/doctor.

Sika Deutschland GmbH, Kornwestheimer Str. 103-107, 70439 Stuttgart, GERMANY, +49 711 8009-0, [email protected], www.sika.com